INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
CM
Chan MitchellDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
Page 1035 of 1737
← PrevNext →
traded Mar 28, 2026
+3d
SEC Form 4

Evidence

21
PM
Preston Tracy MEVP, CLO & Corporate Secretary
MMacy's, Inc.
Option exercise
M—
7,504 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
KA
Kantoff AaronDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
KL
Kinlaw Sheryl LChief Legal Officer
CIACITIZENS, INC.
Option exercise
M—
15.2K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
24.2K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
GL
Guerrero Paula LChief Information Officer
CIACITIZENS, INC.
Option exercise
M—
3,034 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
KL
Kinlaw Sheryl LChief Legal Officer
CIACITIZENS, INC.
Option exercise
M—
10.9K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

20
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale · 10b5-1 plan
SELL$265K
50.0K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

20
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Tax withholding
F$114K
8,241 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

19
TJ
Taylor Randy JSee Remarks
USFDUS Foods Holding Corp.
Tax withholding
F$351K
3,868 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$220K
16.3K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

19
GL
Guerrero Paula LChief Information Officer
CIACITIZENS, INC.
Small acquisition
L$994
178 sh
Feb 27, 2026Mar 31, 2026
traded Feb 27, 2026
+32dSEC Form 4

Evidence

19
EP
Elliott James PaulChief Accounting Officer
FLRFLUOR CORP
Grant or award
A—
1,865 sh
Feb 20, 2026Mar 31, 2026
traded Feb 20, 2026
+39dSEC Form 4

Evidence

19
HQ
Hu QichaoDirector, CEO & CHAIRMAN, 10% Owner
SESSES AI Corp
Tax withholding
F$307K
310.4K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$241K
19.1K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$256K
19.1K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

19
HM
Hoffmann MartinCEO
ONONOn Holding AG
Option exercise
M—
25.0K sh
Mar 20, 2026Mar 31, 2026
traded Mar 20, 2026
+11dSEC Form 4

Evidence

18
LJ
Locascio Dirk J.EVP, Chief Financial Officer
USFDUS Foods Holding Corp.
Open-market sale · 10b5-1 plan
SELL$1.82M
20.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$79K
15.5K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

17
BO
Bron OlivierCEO, Bloomingdale's
MMacy's, Inc.
Option exercise
M—
7,504 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

17
KL
Kennedy Sheryl LynnDirector
CCOICOGENT COMMUNICATIONS HOLDINGS, INC.
Grant or award
A—
3,445 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

17
PS
Peyovich Daniel SPresident & CEO
DYDYCOM INDUSTRIES INC
Grant or award
A—
13.4K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

17
HN
Hertz NoreenaDirector
MATMATTEL INC /DE/
Tax withholding
F$6,321
442 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

17
GJ
Goldman JonathanDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

17
LM
Lewis Bryon MatthewChief Operations Officer
CIACITIZENS, INC.
Option exercise
M—
4,673 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$83K
17.5K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

17
BO
Bron OlivierCEO, Bloomingdale's
MMacy's, Inc.
Option exercise
M—
7,504 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

17
DM
D'Annunzio MarcGeneral Counsel and Secretary
BKKTBakkt, Inc.
Open-market sale · 10b5-1 plan
SELL$55K
6,422 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

17
KL
Kinlaw Sheryl LChief Legal Officer
CIACITIZENS, INC.
Option exercise
M—
15.2K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

17
GL
Guerrero Paula LChief Information Officer
CIACITIZENS, INC.
Option exercise
M—
3,034 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

17
PM
Preston Tracy MEVP, CLO & Corporate Secretary
MMacy's, Inc.
Option exercise
M—
7,504 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

17
RL
Ramshaw Jill LSVP & CHRO
DYDYCOM INDUSTRIES INC
Grant or award
A—
1,177 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

17
WM
Wetherington Kevin MExecutive VP & COO
DYDYCOM INDUSTRIES INC
Grant or award
A—
3,604 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

16
SS
Scrogham StevenCLO, CCO & Corp. Sec.
ACDCProFrac Holding Corp.
Disposition to issuer
D$76K
11.5K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

16
SS
Scrogham StevenCLO, CCO & Corp. Sec.
ACDCProFrac Holding Corp.
Disposition to issuer
D$82K
12.4K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$34K
2,738 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

16
GA
Greenwood Matthew AChief Commercial Officer
ACDCProFrac Holding Corp.
Disposition to issuer
D$76K
11.5K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

16
HA
Harbour AustinChief Financial Officer
ACDCProFrac Holding Corp.
Disposition to issuer
D$130K
19.6K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

16
GA
Greenwood Matthew AChief Commercial Officer
ACDCProFrac Holding Corp.
Disposition to issuer
D$58K
8,762 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

16
NJ
Nealis JingCHIEF FINANCIAL OFFICER
SESSES AI Corp
Tax withholding
F$162K
164.0K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence